|
| Plasticity of melanoma and EMTTF reprogramming |
|
https://doi.org/10.18632/oncotarget.1662
Eugene Tulchinsky, J. Howard Pringle, Julie Caramel, and Stéphane Ansieau
|
| 1-2 |
|
| DNp73: oncotarget in invasion and metastasis |
|
https://doi.org/10.18632/oncotarget.1746
Brigitte M. Pützer
|
| 3-4 |
|
| Breaking Bad: how does a neuronal protein cause neuroendocrine cancer |
|
https://doi.org/10.18632/oncotarget.1710
Karine Pozo, Fiemu E. Nwariaku, and James A Bibb
|
| 5-6 |
|
| A long lasting puzzle for −7/7q− syndrome |
|
https://doi.org/10.18632/oncotarget.1763
Hiroaki Honda, and Toshiya Inaba
|
| 7-8 |
|
| Spherical nucleic acids for precision medicine |
|
https://doi.org/10.18632/oncotarget.1757
Chad A. Mirkin, and Alexander H. Stegh
|
| 9-10 |
|
| Targeting nucleocytoplasmic transport in cancer therapy |
|
https://doi.org/10.18632/oncotarget.1457
Richard Hill, Bastien Cautain, Nuria de Pedro, and Wolfgang Link
|
| 11-28 |
|
| Krüppellike factors in cancer progression: three fingers on the steering wheel |
|
https://doi.org/10.18632/oncotarget.1456
Ridha Limame, Ken Op de Beeck, Filip Lardon, Olivier De Wever, and Patrick Pauwels
|
| 29-48 |
|
| mTOR pathway in colorectal cancer: an update |
|
https://doi.org/10.18632/oncotarget.1548
Maria Giovanna Francipane, and Eric Lagasse
|
| 49-66 |
|
| NF2/Merlin in hereditary neurofibromatosis 2 versus cancer: biologic mechanisms and clinical associations |
|
https://doi.org/10.18632/oncotarget.1557
Rebecca Dunbar Schroeder, Laura S. Angelo, and Razelle Kurzrock
|
| 67-77 |
|
| Perspectives of TGFβ inhibition in pancreatic and hepatocellular carcinomas |
|
https://doi.org/10.18632/oncotarget.1569
Cindy Neuzillet, Armand de Gramont, Annemilaï Tijeras-Raballand, Louis de Mestier, Jérôme Cros, Sandrine Faivre, and Eric Raymond
|
| 78-94 |
|
| A novel immunomodulatory and molecularly targeted strategy for refractory Hodgkin’s lymphoma |
|
https://doi.org/10.18632/oncotarget.1468
Vivek Subbiah, Robert E. Brown, Mary F. McGuire, Jamie Buryanek, Filip Janku, Anas Younes, and David Hong
|
| 95-102 |
|
| The macrophage migration inhibitory factor MIFhomologue Ddopachrome tautomerase is a therapeutic target in a murine melanoma model |
|
https://doi.org/10.18632/oncotarget.1560
Sebastian Kobold, Melanie Merk, Luisa Hofer, Philip Peters, Richard Bucala, and Stefan Endres
|
| 103-107 |
|
| Tumor suppressor genes promote rhabdomyosarcoma progression in p53 heterozygous HER2/neu transgenic mice |
|
https://doi.org/10.18632/oncotarget.1171
Marianna L Ianzano, Stefania Croci, Giordano Nicoletti, Arianna Palladini, Lorena Landuzzi, Valentina Grosso, Dario Ranieri, Massimiliano Dall'Ora, Ilaria Santeramo, Milena Urbini, Carla De Giovanni, Pier Luigi Lollini, and Patrizia Nanni
|
| 108-119 |
|
| MYCN is a novel oncogenic target in pediatric Tcell Acute Lymphoblastic Leukemia |
|
https://doi.org/10.18632/oncotarget.1337
Annalisa Astolfi, Francesca Vendemini, Milena Urbini, Fraia Melchionda, Riccardo Masetti, Monica Franzoni, Virginia Libri, Salvatore Serravalle, Marco Togni, Giuseppina Paone, Luca Montemurro, Daniela Bressanin, Francesca Chiarini, Alberto M Martelli, Roberto Tonelli, and Andrea Pession
|
| 120-130 |
|
| A novel androgenregulated isoform of the TSC2 tumour suppressor gene increases cell proliferation |
|
https://doi.org/10.18632/oncotarget.1405
Jennifer Munkley, Prabhakar Rajan, Nicholas P. Lafferty, Caroline Dalgliesh, Robert M. Jackson, Craig N. Robson, Hing Y. Leung, and David J. Elliott
|
| 131-139 |
|
| Genetic subclonal complexity and miR125a5p downregulation identify a subset of patients with inferior outcome in lowrisk CLL patients |
|
https://doi.org/10.18632/oncotarget.1382
Gian Matteo Rigolin, Elena Saccenti, Lara Rizzotto, Manuela Ferracin, Sara Martinelli, Luca Formigaro, Francesca Cibien, Maurizio Cavallari, Enrico Lista, Giulia Daghia, Olga Sofritti, Maria Ciccone, Francesco Cavazzini, Laura Lupini, Cristian Bassi, Barbara Zagatti, Massimo Negrini, and Antonio Cuneo
|
| 140-149 |
|
| Survivin promoterregulated oncolytic adenovirus with Hsp70 gene exerts effective antitumor efficacy in gastric cancer immunotherapy |
|
https://doi.org/10.18632/oncotarget.1430
Weiguo Wang, Weidan Ji, Huanzhang Hu, Juming Ma, Xiaoya Li, Weiqun Mei, Yang Xu, Hui-Zhen Hu, Yan Yan, Qizhe Song, Zhigang Li, and Changqing Su
|
| 150-160 |
|
| Antitumor activity of the betaadrenergic receptor antagonist propranolol in neuroblastoma |
|
https://doi.org/10.18632/oncotarget.1083
Jennifer K Wolter, Nikolaus E Wolter, Alvaro Blanch, Teresa Partridge, Lynn Cheng, Daniel A. Morgenstern, Monika Podkowa, David R. Kaplan, and Meredith S. Irwin
|
| 161-172 |
|
| Chloroquine synergizes with FTS to enhance cell growth inhibition and cell death |
|
https://doi.org/10.18632/oncotarget.1500
Eran Schmukler, Eya Wolfson, Roni Haklai, Galit Elad-Sfadia, Yoel Kloog, and Ronit Pinkas-Kramarski
|
| 173-184 |
|
| The protooncogene KRAS is targeted by miR200c |
|
https://doi.org/10.18632/oncotarget.1427
Florian Kopp, Ernst Wagner, and Andreas Roidl
|
| 185-195 |
|
| Deficiency in p53 is required for doxorubicin induced transcriptional activation of NFкB target genes in human breast cancer |
|
https://doi.org/10.18632/oncotarget.1556
Alba Dalmases, Irene Gonzalez-Navarrete, Silvia Menendez, Oriol ArpÃ, Josep Maria Coromines, Sonia Servitja, Ignasi Tusquets, Cristina Chamizo, Raúl Rincón, LluÃs Espinosa, Anna Bigas, Pilar Eroles, Jessica Furriol, Anna Lluch, Ana Rovira, Joan Albanell, and Federico Rojo
|
| 196-210 |
|
| AID downregulation is a novel function of the DNMT inhibitor 5azadeoxycytidine |
|
https://doi.org/10.18632/oncotarget.1319
Chiou-Tsun Tsai, Pei-Ming Yang, Ting-Rong Chern, Shu-Hui Chuang, Jung-Hsin Lin, Lars Klemm, Markus Müschen, and Ching-Chow Chen
|
| 211-223 |
|
| A TRAF2 binding independent region of TNFR2 is responsible for TRAF2 depletion and enhancement of cytotoxicity driven by TNFR1 |
|
https://doi.org/10.18632/oncotarget.1492
LucÃa Cabal-Hierro, Noelia Artime, Julián Iglesias, Miguel A. Prado, Lorea Ugarte-Gil, Pedro Casado, Belén Fernández-GarcÃa, Bryant G. Darnay, and Pedro S. Lazo
|
| 224-236 |
|
| Genomewide methylation patterns provide insight into differences in breast tumor biology between American women of African and European ancestry |
|
https://doi.org/10.18632/oncotarget.1599
Christine B. Ambrosone, Allyson C. Young, Lara E. Sucheston, Dan Wang, Li Yan, Song Liu, Li Tang, Qiang Hu, Jo L. Freudenheim, Peter G. Shields, Carl D. Morrison, Kitaw Demissie, and Michael J. Higgins
|
| 237-248 |
|
| Overexpression of 1433θ promotes tumor metastasis and indicates poor prognosis in breast carcinoma |
|
https://doi.org/10.18632/oncotarget.1502
Nanlin Li, Hui Wang, Fan Jing, Chao Tong, Jixin Yang, Hongliang Wei, Jun Yi, and Rui Ling
|
| 249-257 |
|
| Targeting chronic lymphocytic leukemia using CIGB300 a clinicalstage CK2specific cellpermeable peptide inhibitor |
|
https://doi.org/10.18632/oncotarget.1513
Leila R. Martins, Yasser Perera, Paulo Lúcio, Maria G. Silva, Silvio E. Perea, and João T. Barata
|
| 258-263 |
|
| FOXP3 overexpression inhibits melanoma tumorigenesis via effects on proliferation and apoptosis |
|
https://doi.org/10.18632/oncotarget.1600
Bee Shin Tan, Matthew R Anaka, Siddhartha Deb, Claudia Freyer, Lisa M Ebert, Anderly C Chueh, Sheren Al-Obaidi, Andreas Behren, Aparna Jayachandran, Jonathan Cebon, Weisan Chen, and John M Mariadason
|
| 264-276 |
|
| Rac1b negatively regulates TGFβ1induced cell motility in pancreatic ductal epithelial cells by suppressing Smad signalling |
|
https://doi.org/10.18632/oncotarget.1696
Hendrik Ungefroren, Susanne Sebens, Klaudia Giehl, Ole Helm, Stephanie Groth, Fred Faendrich, Christoph Roecken, Bence Sipos, Hendrik Lehnert, and Frank Gieseler
|
| 277-290 |
|
| Poly ADPribose polymerase 1 transcriptional regulation: A novel crosstalk between histone modification H3K9ac and ETS1 motif hypomethylation in BRCA1mutated ovarian cancer |
|
https://doi.org/10.18632/oncotarget.1549
Da Li, Fang-Fang Bi, Ji-Min Cao, Chen Cao, Chun-Yan Li, Bo Liu, and Qing Yang
|
| 291-297 |
|
| Metformin sensitizes anticancer effect of dasatinib in head and neck squamous cell carcinoma cells through AMPKdependent ER stress |
|
https://doi.org/10.18632/oncotarget.1628
Yu-Chin Lin, Meng-Hsuan Wu, Tzu-Tang Wei, Yun-Chieh Lin, Wen-Chih Huang, Liang-Yu Huang, Yi-Ting Lin, and Ching-Chow Chen
|
| 298-308 |
